Clinical Trials Logo

Clinical Trial Summary

The study also determines if eating a diet higher in protein alters body composition, energy balance and metabolic control among patients with a long-chain fatty acid oxidation disorder.


Clinical Trial Description

At baseline, the amount of muscle and fat in the whole body and inside the liver and muscle will be measured. All subjects will complete a moderate treadmill exercise test and a test to determine how they use sugar (oral glucose tolerance test). The amount and type of energy burned by each subject will be measured. Subjects will be randomly assigned to follow either a high carbohydrate diet or a reduced carbohydrate, high protein diet for 4 months. At the end of 4 months, the tests will be repeated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01494051
Study type Interventional
Source Oregon Health and Science University
Contact
Status Completed
Phase Phase 1/Phase 2
Start date January 2006
Completion date January 2010

See also
  Status Clinical Trial Phase
Recruiting NCT05687474 - Baby Detect : Genomic Newborn Screening
Recruiting NCT05910151 - Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Active, not recruiting NCT02635269 - Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy N/A
Completed NCT02517307 - Fatty Acid Oxidation Defects and Insulin Sensitivity N/A
Completed NCT05411835 - Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders Early Phase 1